Literature DB >> 30617579

Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.

Sibel Demirel1, Gökçen Özcan2, Özge Yanık3, Figen Batıoğlu2, Emin Özmert2.   

Abstract

PURPOSE: To concurrently evaluate the effect of half-fluence photodynamic therapy (hf PDT) on choriocapillaris (CC) perfusion and choroidal structure in chronic central serous chorioretinopathy (CSC).
METHODS: This prospective study included 48 eyes of 41 patients with chronic CSC. Enhanced depth imaging optical coherence tomography and optical coherence tomography angiography (OCTA) images were analyzed. Choroidal area (CA), luminal area (LA), and stromal area (SA) were computed using Image J software.
RESULTS: One month after hf-PDT, total CA decreased to 1.312 mm2 from 1.490 mm2 (p < 0.001), LA decreased to 0.981 mm2 from 1.097 mm2 (p < 0.001), and SA decreased to 0.331 mm2 from 0.393 mm2 (p < 0.001). In OCTA, the CC flow in the eyes with CSC (17.75 mm2) was statistically significantly lower than the fellow eyes (18.93 mm2) at the baseline visit (p < 0.001). After hf-PDT, the flow in the choriocapillaris statistically significantly increased to 18.81 mm2 at the first month (p = 0.02).
CONCLUSIONS: OCTA proves that after hf-PDT a significant increase in CC perfusion occurred at first month. The decrease of the luminal areas in enhanced depth imaging optical coherence tomography is mainly due to a decrease in large-caliber vessels, which indicates that hf-PDT has an effect on larger choroidal vessels and spares CC flow.

Entities:  

Keywords:  Choriocapillaris perfusion; Chronic central serous chorioretinopathy; Half-fluence photodynamic therapy; Optical coherence tomography angiography

Mesh:

Substances:

Year:  2019        PMID: 30617579     DOI: 10.1007/s00417-018-04226-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  31 in total

1.  OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY IN CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Szy Yann Chan; Qian Wang; Wen Bin Wei; Jost B Jonas
Journal:  Retina       Date:  2016-11       Impact factor: 4.256

2.  Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.

Authors:  Marco Antonio Bonini Filho; Talisa E de Carlo; Daniela Ferrara; Mehreen Adhi; Caroline R Baumal; Andre J Witkin; Elias Reichel; Jay S Duker; Nadia K Waheed
Journal:  JAMA Ophthalmol       Date:  2015-08       Impact factor: 7.389

3.  Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography.

Authors:  Maddalena Quaranta-El Maftouhi; Adil El Maftouhi; Chiara M Eandi
Journal:  Am J Ophthalmol       Date:  2015-06-29       Impact factor: 5.258

4.  Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy.

Authors:  Massimo Nicoló; Chiara M Eandi; Camilla Alovisi; Federico M Grignolo; Carlo Enrico Traverso; Donatella Musetti; Felice Cardillo Piccolino
Journal:  Am J Ophthalmol       Date:  2014-01-30       Impact factor: 5.258

5.  Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study.

Authors:  Rufino M Silva; Jose M Ruiz-Moreno; Francisco Gomez-Ulla; Javier A Montero; Tatiana Gregório; Maria L Cachulo; Isabel A Pires; José G Cunha-Vaz; Joaquim N Murta
Journal:  Retina       Date:  2013-02       Impact factor: 4.256

6.  Acetazolamide for central serous retinopathy.

Authors:  Joseph Pikkel; Itzchak Beiran; Avinoam Ophir; Benjamin Miller
Journal:  Ophthalmology       Date:  2002-09       Impact factor: 12.079

7.  Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Ricky Y K Lai; David T L Liu; Dennis S C Lam
Journal:  Ophthalmology       Date:  2008-06-05       Impact factor: 12.079

8.  Fundus autofluorescence before and after photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  Emin Ozmert; Figen Batioğlu
Journal:  Ophthalmologica       Date:  2009-04-02       Impact factor: 3.250

9.  Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Ricky Y K Lai; Emily W H Tang; David T L Liu; Dennis S C Lam
Journal:  Retina       Date:  2008-01       Impact factor: 4.256

10.  Optical Coherence Tomography Angiography in Central Serous Chorioretinopathy.

Authors:  Eliana Costanzo; Salomon Yves Cohen; Alexandra Miere; Giuseppe Querques; Vittorio Capuano; Oudy Semoun; Ala'a El Ameen; Hassiba Oubraham; Eric H Souied
Journal:  J Ophthalmol       Date:  2015-11-08       Impact factor: 1.909

View more
  8 in total

1.  Early response to the treatment of choroidal neovascularization complicating central serous chorioretinopathy: a OCT-angiography study.

Authors:  Riccardo Sacconi; Livia Tomasso; Eleonora Corbelli; Adriano Carnevali; Lea Querques; Stefano Casati; Francesco Bandello; Giuseppe Querques
Journal:  Eye (Lond)       Date:  2019-07-02       Impact factor: 3.775

2.  Flat irregular pigment epithelial detachment over time and outcome of different treatment regimens.

Authors:  Nazanin Ebrahimiadib; Mohammadreza Mehrabi Bahar; Hamid Riazi-Esfahani; Elias Khalili Pour; Fariba Ghassemi; Hooshang Faghihi; Ahmad Mirshahi; Ramak Roohipourmoallai; Alireza Lashay; Alireza Mahmoudi; Kaveh Fadakar
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

3.  Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study.

Authors:  Claudio Iovino; Enrico Peiretti; Filippo Tatti; Giuseppe Querques; Enrico Borrelli; Riccardo Sacconi; Jay Chhablani; Hitesh Agrawal; Camiel J F Boon; Elon H C van Dijk; Gilda Cennamo; Marco Lupidi; Alessio Muzi; Valentina Di Iorio; Matias Iglicki; Lital Smadar; Anat Loewenstein; Dinah Zur
Journal:  Eye (Lond)       Date:  2021-04-06       Impact factor: 3.775

Review 4.  Evaluation of the choriocapillaris after photodynamic therapy for chronic central serous chorioretinopathy. A review of optical coherence tomography angiography (OCT-A) studies.

Authors:  Evita Evangelia Christou; Panagiotis Stavrakas; Vassilios Kozobolis; Andreas Katsanos; Ilias Georgalas; Maria Stefaniotou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-19       Impact factor: 3.117

5.  Quantitative evaluation of choriocapillaris using optical coherence tomography and optical coherence tomography angiography in patients with central serous chorioretinopathy after half-dose photodynamic therapy.

Authors:  Hyun Seung Yang; Tae Gu Kang; Hyun Park; Ji Su Heo; Jonghoon Park; Kyung Sub Lee; Sangkyung Choi
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

6.  Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy.

Authors:  Chizu Yamada; Ryo Mukai; Yoichiro Shinohara; Hidetaka Matsumoto; Hideo Akiyama
Journal:  Cureus       Date:  2022-08-04

7.  Visualization of deep choroidal vasculatures and measurement of choroidal vascular density: a swept-source optical coherence tomography angiography approach.

Authors:  Erqian Wang; Xinyu Zhao; Jingyuan Yang; Youxin Chen
Journal:  BMC Ophthalmol       Date:  2020-08-05       Impact factor: 2.209

Review 8.  Applications of Multimodal Imaging in Central Serous Chorioretinopathy Evaluation.

Authors:  Mary Ho; Gabriel Li; Andrew Mak; Danny Ng; Lawrence Iu; Frank Lai
Journal:  J Ophthalmol       Date:  2021-07-24       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.